Published in Clin Nutr on January 08, 2010
Cachexia in Gynecological Cancer and the Preventive Role of Weight Training | NCT03200639
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing (2010) 17.45
Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54
Association of anorexia with sarcopenia in a community-dwelling elderly population: results from the ilSIRENTE study. Eur J Nutr (2012) 2.27
Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci (2014) 2.02
Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov (2015) 1.90
An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle (2010) 1.89
An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci (2014) 1.65
Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing (2013) 1.62
Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int (2012) 1.58
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab (2012) 1.56
Hospital malnutrition: prevalence, identification and impact on patients and the healthcare system. Int J Environ Res Public Health (2011) 1.56
Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc (2010) 1.51
Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle (2014) 1.50
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res (2015) 1.49
Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Dordr) (2013) 1.42
Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting. J Exp Clin Cancer Res (2016) 1.41
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol (2013) 1.38
Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle (2012) 1.37
Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol (2014) 1.33
Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci (2013) 1.33
Optimal management of sarcopenia. Clin Interv Aging (2010) 1.29
Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci (2014) 1.26
Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol (2014) 1.24
From muscle wasting to sarcopenia and myopenia: update 2012. J Cachexia Sarcopenia Muscle (2012) 1.23
The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse. PLoS One (2011) 1.20
Quality of life in sarcopenia and frailty. Calcif Tissue Int (2013) 1.17
Dietary advanced glycation end products and aging. Nutrients (2010) 1.16
Interleukin 6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev (2010) 1.16
Myopenia-a new universal term for muscle wasting. J Cachexia Sarcopenia Muscle (2011) 1.12
Sarcopenia: burden and challenges for public health. Arch Public Health (2014) 1.09
Tools in the assessment of sarcopenia. Calcif Tissue Int (2013) 1.09
Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle (2012) 1.08
Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop. J Bone Miner Res (2013) 1.06
Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food. Clin Nutr (2011) 1.06
Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia. J Cachexia Sarcopenia Muscle (2011) 1.06
Osteoporosis and sarcopenia in older age. Bone (2015) 1.05
Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle (2011) 1.05
Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol (2015) 1.05
IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse. Skelet Muscle (2012) 1.02
Skeletal muscle apoptotic signaling predicts thigh muscle volume and gait speed in community-dwelling older persons: an exploratory study. PLoS One (2012) 1.02
Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia. FASEB J (2013) 1.01
Influence of cancer cachexia on drug liver metabolism and renal elimination in rats. J Cachexia Sarcopenia Muscle (2015) 0.98
Molecular genetic studies of gene identification for sarcopenia. Hum Genet (2011) 0.97
Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise. J Cachexia Sarcopenia Muscle (2011) 0.97
One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA. Drugs Context (2014) 0.96
Clinical definition of sarcopenia. Clin Cases Miner Bone Metab (2014) 0.96
Pharmacokinetics of drugs in cachectic patients: a systematic review. PLoS One (2013) 0.95
The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachexia Sarcopenia Muscle (2011) 0.94
Mass spectrometry-based proteomic analysis of middle-aged vs. aged vastus lateralis reveals increased levels of carbonic anhydrase isoform 3 in senescent human skeletal muscle. Int J Mol Med (2012) 0.94
Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int (2015) 0.94
Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer (2015) 0.94
The role of dietary protein intake in the prevention of sarcopenia of aging. Nutr Clin Pract (2013) 0.93
Role of Inflammation in Muscle Homeostasis and Myogenesis. Mediators Inflamm (2015) 0.93
Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study. J Am Geriatr Soc (2015) 0.93
Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review. Gerontology (2014) 0.93
The epidemiology of sarcopenia in community living older adults: what role does lifestyle play? J Cachexia Sarcopenia Muscle (2011) 0.92
NRF2 and the Phase II Response in Acute Stress Resistance Induced by Dietary Restriction. J Clin Exp Pathol (2012) 0.92
Survival of the fattest: unexpected findings about hyperglycaemia and obesity in a population based study of 75-year-olds. BMJ Open (2011) 0.91
Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis. Front Nutr (2014) 0.91
Skeletal muscle function deficit: a new terminology to embrace the evolving concepts of sarcopenia and age-related muscle dysfunction. J Gerontol A Biol Sci Med Sci (2014) 0.90
Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004. J Cachexia Sarcopenia Muscle (2013) 0.90
Sarcopenia in stroke-facts and numbers on muscle loss accounting for disability after stroke. J Cachexia Sarcopenia Muscle (2011) 0.90
Sarcopenia is an Independent Predictor of Severe Postoperative Complications and Long-Term Survival After Radical Gastrectomy for Gastric Cancer: Analysis from a Large-Scale Cohort. Medicine (Baltimore) (2016) 0.89
Sarcopenia - pathophysiology and clinical relevance. Wien Med Wochenschr (2011) 0.89
Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research. J Cachexia Sarcopenia Muscle (2015) 0.89
Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy. Support Care Cancer (2014) 0.89
Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer (2012) 0.88
The potential of classic and specific bioelectrical impedance vector analysis for the assessment of sarcopenia and sarcopenic obesity. Clin Interv Aging (2012) 0.88
Searching for a relevant definition of sarcopenia: results from the cross-sectional EPIDOS study. J Cachexia Sarcopenia Muscle (2015) 0.88
Proteomic Profiling of Mitochondrial Enzymes during Skeletal Muscle Aging. J Aging Res (2011) 0.88
The Predictive Value of the EWGSOP Definition of Sarcopenia: Results From the InCHIANTI Study. J Gerontol A Biol Sci Med Sci (2015) 0.88
Exercise attenuates the major hallmarks of aging. Rejuvenation Res (2015) 0.87
Current nutritional recommendations and novel dietary strategies to manage sarcopenia. J Frailty Aging (2013) 0.87
Development and relative validity of a new field instrument for detection of geriatric cachexia: preliminary analysis in hip fracture patients. J Cachexia Sarcopenia Muscle (2013) 0.87
Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3. PLoS One (2014) 0.87
Sarcopenia-related parameters and incident disability in older persons: results from the "invecchiare in Chianti" study. J Gerontol A Biol Sci Med Sci (2014) 0.87
Cachexia: a problem of energetic inefficiency. J Cachexia Sarcopenia Muscle (2014) 0.86
Anorexia of aging: a modifiable risk factor for frailty. Nutrients (2013) 0.86
Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer. World J Surg Oncol (2014) 0.86
Methods, diagnostic criteria, cutoff points, and prevalence of sarcopenia among older people. ScientificWorldJournal (2014) 0.85
Reproducibility of jumping mechanography and traditional measures of physical and muscle function in older adults. Osteoporos Int (2014) 0.85
Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Arch Med Sci (2013) 0.85
New molecular targets and lifestyle interventions to delay aging sarcopenia. Front Aging Neurosci (2014) 0.84
Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome. Insights Imaging (2015) 0.84
Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models. J Lipid Res (2013) 0.84
Early-stage chronic kidney disease, insulin resistance, and osteoporosis as risk factors of sarcopenia in aged population: the fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008-2009. Osteoporos Int (2014) 0.84
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS One (2017) 0.84
Prevalence of sarcopenia and associated factors among Thai population. J Bone Miner Metab (2013) 0.84
The effect of disease activity on body composition and resting energy expenditure in patients with rheumatoid arthritis. J Inflamm Res (2011) 0.84
The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A/CS and the VAS for appetite. Support Care Cancer (2015) 0.83
Seropositivity for CMV and IL-6 levels are associated with grip strength and muscle size in the elderly. Immun Ageing (2013) 0.83
Androgen effects on skeletal muscle: implications for the development and management of frailty. Asian J Androl (2014) 0.83
Frequency of sarcopenia and associated factors among hospitalized elderly patients. BMC Musculoskelet Disord (2015) 0.81
Classifying aging as a disease in the context of ICD-11. Front Genet (2015) 0.81
Sarcopenia in daily practice: assessment and management. BMC Geriatr (2016) 0.81
A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy. J Cachexia Sarcopenia Muscle (2015) 0.81
Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia. Cancer Biol Ther (2011) 0.81
Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations. J Nutr Health Aging (2013) 0.81
Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy. Rep Pract Oncol Radiother (2015) 0.81
Sarcopenia, a neurogenic syndrome? J Aging Res (2013) 0.81
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr (2006) 3.36
The endotoxin-lipoprotein hypothesis. Lancet (2000) 3.03
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J (1998) 2.73
Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg (1994) 2.69
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging (2008) 2.54
Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax (2001) 2.50
In 1995 a correlation between malnutrition and poor outcome in critically ill patients still exists. Nutrition (1996) 2.40
Outcome of patients with abdominal sepsis treated in an intensive care unit. Br J Surg (1995) 2.38
A history of the term radical behaviorism: From Watson to Skinner. Behav Anal (1987) 2.28
Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1997) 2.27
Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol (1997) 2.19
Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation (2000) 2.18
Teaching emergency medicine residents evidence-based critical appraisal skills: a controlled trial. Ann Emerg Med (1999) 2.13
Quadriceps muscle strength in scoliosis. Eur Respir J (2009) 2.11
Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer (1995) 2.09
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol (1997) 2.08
Prediction of risk in biliary surgery. Br J Surg (1983) 2.07
Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J (2000) 2.06
Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol (1997) 2.05
Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. J Natl Cancer Inst (1987) 2.02
Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J (1998) 1.97
Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg (2001) 1.96
Decreased food intake is a risk factor for mortality in hospitalised patients: the NutritionDay survey 2006. Clin Nutr (2009) 1.94
Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis. Br J Surg (2000) 1.87
Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging (2009) 1.85
Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis (1993) 1.80
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation (2001) 1.75
Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) (2000) 1.74
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol (2001) 1.71
Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol (1999) 1.71
The digestion rate of protein is an independent regulating factor of postprandial protein retention. Am J Physiol Endocrinol Metab (2001) 1.66
Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Eur Heart J (2000) 1.66
Adipose tissue fatty acids and insulin sensitivity in elderly men. Diabetologia (2010) 1.64
Frequent users of the emergency department: can we intervene? Acad Emerg Med (1997) 1.64
Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition (2000) 1.63
Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr (2001) 1.60
Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int (2012) 1.58
Treatment of protein-energy malnutrition in chronic nonmalignant disorders. Am J Clin Nutr (2001) 1.56
Sarcopenia and frailty: a clinician's controversial point of view. Exp Gerontol (2008) 1.54
Specific and nonspecific immune responses to fasting and refeeding differ in healthy young adult and elderly persons. Am J Clin Nutr (2001) 1.54
Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight. Eur Heart J (2001) 1.53
Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer (1997) 1.52
Laparotomy for abdominal sepsis in the critically ill. Br J Surg (1996) 1.50
Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab (1996) 1.50
Leucine and phenylalanine kinetics in compensated liver cirrhosis: effects of insulin. Gastroenterology (1993) 1.50
Body mass index, weight change and mortality in the elderly. A 15 y longitudinal population study of 70 y olds. Eur J Clin Nutr (2001) 1.49
Endothelial-derived selectins in the development of organ dysfunction in acute pancreatitis. Crit Care Med (2001) 1.49
Response of phenylalanine and leucine kinetics to branched chain-enriched amino acids and insulin in patients with cirrhosis. Gastroenterology (1996) 1.48
Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer (1994) 1.48
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis. Ann Rheum Dis (2003) 1.48
Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. Eur Heart J (2001) 1.47
The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer (1999) 1.46
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab (1993) 1.45
Ageing and muscle: the effects of malnutrition, re-nutrition, and physical exercise. Curr Opin Clin Nutr Metab Care (2001) 1.45
Postprandial chylomicron and plasma vitamin E responses in healthy older subjects compared with younger ones. Eur J Clin Invest (1997) 1.45
The impact of cachexia on cardiorespiratory reflex control in chronic heart failure. Eur Heart J (1999) 1.44
Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1 activity indices in dialysis patients. J Intern Med (2012) 1.40
Characteristics of Escherichia coli strains belonging to enteropathogenic E. coli serogroups isolated in Italy from children with diarrhea. J Clin Microbiol (1996) 1.40
The model of the clinical practice of emergency medicine. Ann Emerg Med (2001) 1.40
[Relationship between nutritional intervention and quality of life in cancer patients]. Nutr Hosp (2007) 1.39
Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart disease. Eur Heart J (2000) 1.39
Pathogenesis of cancer anorexia: personal perspective. Nutrition (1997) 1.39
Cortisol and the muscle-bone axis. Osteoporos Int (2014) 1.39
Total body potassium, skeletal muscle potassium and magnesium in patients with Bartter's syndrome. Scand J Clin Lab Invest (1990) 1.38
Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation (1997) 1.38
Effects of acute systemic hyperinsulinemia on forearm muscle proteolysis in healthy man. J Clin Invest (1991) 1.38
ESPEN Guidelines on Enteral Nutrition: Geriatrics. Clin Nutr (2006) 1.37
Protein pulse feeding improves protein retention in elderly women. Am J Clin Nutr (1999) 1.36
Insulin resistance: a contributing factor to age-related muscle mass loss? Diabetes Metab (2005) 1.36
Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition. J Clin Invest (1987) 1.36
The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition (1996) 1.34
Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation (2001) 1.33
Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients. Diabetologia (2004) 1.32
A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg (1995) 1.32
Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol (1999) 1.32
Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc Natl Acad Sci U S A (1996) 1.31
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer (2000) 1.31
Albumin and fibrinogen syntheses increase while muscle protein synthesis decreases in head-injured patients. Am J Physiol (1997) 1.31
Emergency department management of mild traumatic brain injury in the USA. Emerg Med J (2005) 1.29
Dose-response curves of effects of insulin on leucine kinetics in humans. Am J Physiol (1986) 1.28
Gastrointestinal and colonic segmental transit time evaluated by a single abdominal x-ray in healthy subjects and constipated patients. Scand J Gastroenterol Suppl (1988) 1.26
Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer. Clin Sci (Lond) (1999) 1.25
Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA (1995) 1.25
Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: clinical implications and role of augmented peripheral chemosensitivity. Circulation (1999) 1.25
Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg (1996) 1.23
Androgens and erythropoiesis: past and present. J Endocrinol Invest (2009) 1.23
Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor. Kidney Int (1999) 1.23
Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun (1999) 1.23
Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer (1999) 1.22
Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet (1998) 1.22
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer (2000) 1.22
Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut (2002) 1.21
Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol (1997) 1.21